Clinical Trial Update: Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery [Phase 1]

View source ↗

Summary

Phase 1 study of trastuzumab emtansine for HER2-positive metastatic or locally advanced breast cancer that cannot be removed by surgery has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab emtansine (ado-trastuzumab emtansine)

Snippet

Sponsor: University of Washington | Conditions: HER2/Neu Positive, Recurrent Breast Carcinoma | Phase 1 | Status: COMPLETED